Dr. Dhaval G. Aghera, M.D.
Nephrology (Kidney) (Nephrology Physician)
200 E 33rd St Ste 523
Baltimore, MD 21218
Who else practices at this address →
Baltimore city includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 424
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
MD license D79315
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sinai Hospital of Baltimore Baltimore, MD
- Medstar Union Memorial Hospital Baltimore, MD
- Medstar Good Samaritan Hospital Baltimore, MD
- Levindale Hebrew Geriatric Center and Hospital Baltimore, MD
Medical groups
- Washington Nephrology Associates LLP (35 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 424
- Services billed
- 2,419
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 573 | 156 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 537 | 162 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 254 | 36 |
| Established patient office or other outpatient visit, 30-39 minutes | 235 | 124 |
| Hemodialysis procedure with physician evaluation | 192 | 48 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 139 | 128 |
| Established patient office or other outpatient visit, 40-54 minutes | 116 | 48 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | 16 |
| New patient office or other outpatient visit, 45-59 minutes | 30 | 30 |
| Transitional care management services for problem of high complexity | 25 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Allopurinol Other prescribers in Baltimore, MD | 104 |
| Torsemide Other prescribers in Baltimore, MD | 87 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Baltimore, MD | 83 |
| Amlodipine Besylate Other prescribers in Baltimore, MD | 78 |
| Jardiance (empagliflozin) Other prescribers in Baltimore, MD | 77 |
| Losartan Potassium Other prescribers in Baltimore, MD | 64 |
| Carvedilol Other prescribers in Baltimore, MD | 59 |
| Atorvastatin Calcium Other prescribers in Baltimore, MD | 57 |
| Lisinopril Other prescribers in Baltimore, MD | 44 |
| Nifedipine Er (nifedipine) Other prescribers in Baltimore, MD | 43 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 27 payments worth $520 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $67.74 |
|---|---|
| Aurinia Pharma U.S., Inc. | $46.89 |
| Travere Therapeutics, Inc. | $46.46 |
| Akebia Therapeutics Inc | $45.26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.86 |
| Scpharmaceuticals Inc. | $35.75 |
| Calliditas Therapeutics US Inc. | $32.18 |
| Bayer HealthCare Pharmaceuticals Inc. | $31.20 |
| Food and Beverage | $520 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.